Marquette Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Marquette Asset Management's ABBV Position: Q2 2026 in Review
Marquette Asset Management increased its AbbVie (ABBV) stake by 52% in Q2 2026, buying an estimated $10.3K and bringing the position to 140 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #189.
Marquette Asset Management first reported a position in ABBV in Q1 2019 and has held it in 22 quarters since. The position peaked at $93K in Q1 2025. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Marquette Asset Management held 140 shares of AbbVie worth $35.2K as of Q2 2026.
- Marquette Asset Management bought 48 AbbVie shares in Q2 2026, an estimated $10.3K.
- AbbVie made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #189 holding.
- Marquette Asset Management first reported a position in AbbVie in Q1 2019 and has held it in 22 quarters since.
- Marquette Asset Management's AbbVie position peaked at $93K in Q1 2025.
- 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.